Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The immune system's response to desensitization involves controlled exposure to *Ambrosia artemisiifolia* allergens, aiming to retrain the immune system and reduce or eliminate allergic symptoms over time. This process involves shifting the immune response from a Th2-mediated inflammatory state to a more tolerant state through the induction of regulatory T cells and blocking IgG4 antibodies. The primary target allergens are proteins found in ragweed pollen, with Amb a 1 being the most prevalent and clinically relevant.
Induction of immune tolerance through repeated controlled antigen exposure, shifting the immune response from Th2-mediated inflammation to T regulatory cell-mediated suppression and IgG4 antibody production.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Immune system (desensitization via exposure to *Ambrosia artemisiifolia* allergens).